Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PIG-F Inhibitors

PIG-F inhibitors, also known as phosphatidylinositol glycan class F inhibitors, belong to a specialized category of chemical compounds designed to target a specific enzymatic pathway within the cell membrane. These inhibitors are characterized by their ability to modulate the activity of the PIG-F enzyme, which plays a crucial role in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors. GPI anchors are complex glycolipids that serve as membrane anchors for a wide range of cell surface proteins, including receptors and adhesion molecules. The addition of GPI anchors is essential for the proper localization and functioning of these proteins on the cell surface.

PIG-F inhibitors involves interfering with the enzymatic reactions responsible for GPI anchor synthesis. By doing so, these inhibitors disrupt the normal process of anchoring proteins to the cell membrane. This targeted interference can have a profound impact on various cellular processes and signaling pathways, ultimately affecting cell adhesion, signal transduction, and the overall organization of cell membranes. PIG-F inhibitors are valuable tools in cellular and molecular biology research, enabling scientists to investigate the functions of GPI-anchored proteins and explore the consequences of their absence or malfunction. Additionally, the development and study of PIG-F inhibitors have provided valuable insights into the broader field of lipid biochemistry and membrane biology, contributing to our understanding of cell structure and function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Targets VEGFR, which is part of the same family as PIGFR, potentially reducing PIGF-mediated angiogenesis.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Inhibits RAF kinase, VEGFR, and PDGFR, which are involved in downstream signaling of PIGF.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Blocks VEGFR, PDGFR, and c-KIT, affecting pathways that PIGF may be part of.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

Targets VEGFR, which might interfere with PIGF-related signaling.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$94.00
$208.00
1
(1)

Inhibits multiple tyrosine kinases including VEGFR, potentially impacting PIGF-mediated effects.

Regorafenib

755037-03-7sc-477163
sc-477163A
25 mg
50 mg
$320.00
$430.00
3
(0)

Targets VEGFR amongst others, which could alter PIGF-related pathways.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Inhibits EGFR, and indirectly could affect PIGF signaling.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Targets EGFR, which could have downstream effects on PIGF signaling.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Inhibits HER2 and EGFR, potentially influencing PIGF signaling indirectly.